| Style | Citing Format |
|---|---|
| MLA | Nematbakhsh M. "Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects." International Journal of Preventive Medicine, vol. 16, no. , 2025, pp. -. |
| APA | Nematbakhsh M (2025). Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects. International Journal of Preventive Medicine, 16(), -. |
| Chicago | Nematbakhsh M. "Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects." International Journal of Preventive Medicine 16, no. (2025): -. |
| Harvard | Nematbakhsh M (2025) 'Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects', International Journal of Preventive Medicine, 16(), pp. -. |
| Vancouver | Nematbakhsh M. Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects. International Journal of Preventive Medicine. 2025;16():-. |
| BibTex | @article{ author = {Nematbakhsh M}, title = {Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects}, journal = {International Journal of Preventive Medicine}, volume = {16}, number = {}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Nematbakhsh M TI - Methotrexate in Rheumatoid Arthritis and in Cancers: Gender Is a Serious Variable for Effectiveness and for Prevention of Side Effects JO - International Journal of Preventive Medicine VL - 16 IS - SP - EP - PY - 2025 ER - |